Catalyst Wire Dossier Catalyst Wire Dossier

OTX-TKI

· Ocular Therapeutix, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OTX-TKI, covering 2024-07-10 to 2024-07-10. Get the full timeline:

Most recent: Clinical Trial Update: CLN-0046: Treatment of AMD Subjects With OTX-TKI [Phase 1]

See pricing